🔴 Noveris Health Sciences is trading 5.41% down today amid a 2.47% biotech-sector decline

Noveris Health Sciences is trading at CA$0.17 (-5.41%) amid broader biotech-sector weakness.

• No new company-specific announcement was identified on August 20, 2026.
• The decline follows extreme volatility, including a 40.98% drop on August 18 and a 38.64% rebound on August 17.
• Biotech stocks are broadly weaker, with the sector down 2.47%, and major U.S. indices opened lower. The August 18 USPTO allowance and CA$146,000 API work order remain the latest company news but do not directly explain today’s decline.